The store will not work correctly when cookies are disabled.
6-Bromo-8-methyl-2-((pyrimidin-2-ylthio)methyl)quinazolin-4(3H)-one
ID: ALA5181770
Chembl Id: CHEMBL5181770
PubChem CID: 168277556
Max Phase: Preclinical
Molecular Formula: C14H11BrN4OS
Molecular Weight: 363.24
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(Br)cc2c(=O)[nH]c(CSc3ncccn3)nc12
Standard InChI: InChI=1S/C14H11BrN4OS/c1-8-5-9(15)6-10-12(8)18-11(19-13(10)20)7-21-14-16-3-2-4-17-14/h2-6H,7H2,1H3,(H,18,19,20)
Standard InChI Key: UYAVGZOEYLNVKI-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Calculated Properties
| Molecular Weight: 363.24 | Molecular Weight (Monoisotopic): 361.9837 | AlogP: 3.08 | #Rotatable Bonds: 3 |
| Polar Surface Area: 71.53 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 9.70 | CX Basic pKa: 4.71 | CX LogP: 2.80 | CX LogD: 2.81 |
| Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.57 | Np Likeness Score: -1.96 |
References
| 1. Kirby IT, Person A, Cohen M.. (2021) Rational design of selective inhibitors of PARP4., 12 (11.0): [PMID:34825190] [10.1039/D1MD00195G] |
